Kazuo Komiyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kazuo Komiyama has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Mitsuhiko Matsumoto
5 shared publications- Naoyuki Matsumoto
Department of Pathology, Nihon University School of Dentistry
5 shared publications Hidero Ohki
4 shared publicationsHiroshi Tanaka
4 shared publicationsItaru Moro
The Department of Pathology, and
3 shared publicationsMasahiro Okaue
Oral and Maxillo-facial Surgery
3 shared publications
Latest Publications
- 1 April 2016
- Vol. 36 (4) , 1571-9
Rapid and Specific Screening Assay for KRAS Oncogene Mutation by a Novel Gene Amplification Method.
Epidermal growth factor receptor (EGFR) is a target of molecular therapeutics for colorectal cancer. However, mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) gene at codons 12 and 13 attenuates the therapeutic effect of anti-EGFR therapies. Therefore, the detection of KRAS gene mutation is important for therapeutic decision-making. KRAS gene mutation at codons 12 (c.34G>T, c.35G>C, c.35G>A) and 13 (c.38G>A) in six cancer cell lines were investigated. A loop-mediated isothermal amplification-based procedure was developed that employed peptide nucleic acid to suppress amplification of the wild-type allele. This mutation-oriented gene-amplification procedure can amplify the DNA fragment of the KRAS gene with codon 12 and codon 13 mutation within 30 min. Moreover, boiled cells can work as template resources. This newly developed procedure can be useful for patient stratification for anti-EGFR therapies.
- 1 April 2016
- Vol. 36 (4) , 1571-9
Rapid and Specific Screening Assay for KRAS Oncogene Mutation by a Novel Gene Amplification Method.
Epidermal growth factor receptor (EGFR) is a target of molecular therapeutics for colorectal cancer. However, mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) gene at codons 12 and 13 attenuates the therapeutic effect of anti-EGFR therapies. Therefore, the detection of KRAS gene mutation is important for therapeutic decision-making. KRAS gene mutation at codons 12 (c.34G>T, c.35G>C, c.35G>A) and 13 (c.38G>A) in six cancer cell lines were investigated. A loop-mediated isothermal amplification-based procedure was developed that employed peptide nucleic acid to suppress amplification of the wild-type allele. This mutation-oriented gene-amplification procedure can amplify the DNA fragment of the KRAS gene with codon 12 and codon 13 mutation within 30 min. Moreover, boiled cells can work as template resources. This newly developed procedure can be useful for patient stratification for anti-EGFR therapies.
- 1 January 2016
- Published by Japanese Society of Oral and Maxillofacial Surgeons in Japanese Journal of Oral and Maxillofacial Surgery
- Vol. 62 (11) , 561-565
A case of Hodgkin’s lymphoma arising in the maxillary gingiva
We report a case of Hodgkin’s lymphoma that involved the maxillary gingiva and bilateral cervical lymph nodes. The patient was an 89-year-old woman who complained about an ulcer in the right maxillary gingiva and swelling of the right cheek. Biopsy specimens taken from the gingiva showed typical Reed-Sternberg (RS) cells within a composite inflammatory milieu. Immunohistochemical analysis showed that the RS cells were positive for CD30, CD15, and CD20, and in situ hybridization analysis revealed that the cells were also positive for EBER1. Thus the disease was finally diagnosed as mixed cellularity Hodgkin’s lymphoma.
- 1 January 2016
- Published by Japanese Society of Oral and Maxillofacial Surgeons in Japanese Journal of Oral and Maxillofacial Surgery
- Vol. 62 (11) , 561-565
A case of Hodgkin’s lymphoma arising in the maxillary gingiva
We report a case of Hodgkin’s lymphoma that involved the maxillary gingiva and bilateral cervical lymph nodes. The patient was an 89-year-old woman who complained about an ulcer in the right maxillary gingiva and swelling of the right cheek. Biopsy specimens taken from the gingiva showed typical Reed-Sternberg (RS) cells within a composite inflammatory milieu. Immunohistochemical analysis showed that the RS cells were positive for CD30, CD15, and CD20, and in situ hybridization analysis revealed that the cells were also positive for EBER1. Thus the disease was finally diagnosed as mixed cellularity Hodgkin’s lymphoma.
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e172
Tam's Polarization and MMPs Expression Level Are Correlated to Metastasis of Oral Squamous Cell Carcinoma
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e172
Tam's Polarization and MMPs Expression Level Are Correlated to Metastasis of Oral Squamous Cell Carcinoma
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e138
Acinic Cell Carcinoma of the Parotid Gland. Fine Needle Aspiration Cytology Findings
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e138
Acinic Cell Carcinoma of the Parotid Gland. Fine Needle Aspiration Cytology Findings
- 1 January 2015
- Published by The Japanese Society of Oral Diagnosis/Oral Medicine in Japanese Journal of Oral Diagnosis / Oral Medicine
- Vol. 28 (3) , 202-207
A Case of Submandibular Lymphadenopathy with IgG4-related Disease
IgG4-related disease is a recently proposed pathological entity characterized by tumor-like enlargement of one or more organs, IgG4 positive plasma cell accumulation and raised serum IgG4 levels. We present a case of submandibular lymphadenopathy with IgG4-related disease. The patient was a 49-year-old man, who had been receiving periodontal treatment in our department. We investigated swelling of the right submandibular region that had been identified previously. An excisional biopsy revealed enlarged lymph nodes. IgG4 positive plasma cells were found in interfollicular areas (IgG4/IgG ratio: 89.5%). Thus, IgG4-related disease was suspected. The serum IgG4 level was high on blood testing, and so we consulted the department of rheumatology. At present, he is asymptomatic except for the head and neck lesions without medication. The patient is on regular follow-up with hematological and radiological examination.
- 1 January 2015
- Published by The Japanese Society of Oral Diagnosis/Oral Medicine in Japanese Journal of Oral Diagnosis / Oral Medicine
- Vol. 28 (3) , 202-207
A Case of Submandibular Lymphadenopathy with IgG4-related Disease
IgG4-related disease is a recently proposed pathological entity characterized by tumor-like enlargement of one or more organs, IgG4 positive plasma cell accumulation and raised serum IgG4 levels. We present a case of submandibular lymphadenopathy with IgG4-related disease. The patient was a 49-year-old man, who had been receiving periodontal treatment in our department. We investigated swelling of the right submandibular region that had been identified previously. An excisional biopsy revealed enlarged lymph nodes. IgG4 positive plasma cells were found in interfollicular areas (IgG4/IgG ratio: 89.5%). Thus, IgG4-related disease was suspected. The serum IgG4 level was high on blood testing, and so we consulted the department of rheumatology. At present, he is asymptomatic except for the head and neck lesions without medication. The patient is on regular follow-up with hematological and radiological examination.
- 1 April 2014
- Vol. 34 (4) , 1701-8
Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.
Tumor angiogenesis is a focus of molecularly-targeted therapies. This study investigated the effect of sodium butyrate (SB), a histone deacetylase inhibitor, on the synthesis of antiangiogenic and lymphangiogenic factors in oral squamous cell carcinoma. Gene alterations in HSC-3 cells were assessed using cDNA microarrays before and after treatment with SB. The mRNA and protein expression of lymphangiogenic factors were also assessed by quantitative PCR, western blotting and immunocytochemistry. Microarray analysis revealed that treatment with SB led to altered expression of angiogenesis-related gene expression. The quantitative polymerase chain reaction showed that platelet-derived growth factor-B, angiopoietin-2, vascular endothelial growth factor (VEGF)-C, and VEGFD were down-regulated. Western blotting and immunocytochemistry confirmed reduced protein synthesis of VEGFC. SB inhibits expression of lymphangiogenic factors in HSC-3 cells. Within the limitations of the present study, SB may have potential as an anti-metastatic pro-drug for oral cancer.
- 1 April 2014
- Vol. 34 (4) , 1701-8
Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.
Tumor angiogenesis is a focus of molecularly-targeted therapies. This study investigated the effect of sodium butyrate (SB), a histone deacetylase inhibitor, on the synthesis of antiangiogenic and lymphangiogenic factors in oral squamous cell carcinoma. Gene alterations in HSC-3 cells were assessed using cDNA microarrays before and after treatment with SB. The mRNA and protein expression of lymphangiogenic factors were also assessed by quantitative PCR, western blotting and immunocytochemistry. Microarray analysis revealed that treatment with SB led to altered expression of angiogenesis-related gene expression. The quantitative polymerase chain reaction showed that platelet-derived growth factor-B, angiopoietin-2, vascular endothelial growth factor (VEGF)-C, and VEGFD were down-regulated. Western blotting and immunocytochemistry confirmed reduced protein synthesis of VEGFC. SB inhibits expression of lymphangiogenic factors in HSC-3 cells. Within the limitations of the present study, SB may have potential as an anti-metastatic pro-drug for oral cancer.
- Open Access
- 9 June 2010
- Published by Springer Nature in BMC Geriatrics
- Vol. 10 (1) , 35
The Tokyo Oldest Old Survey on Total Health (TOOTH): A longitudinal cohort study of multidimensional components of health and well-being
With the rapid worldwide increase in the oldest old population, considerable concern has arisen about the social and economic burden of diseases and disability in this age group. Understanding of multidimensional structure of health and its life-course trajectory is an essential prerequisite for effective health care delivery. Therefore, we organized an interdisciplinary research team consisting of geriatricians, dentists, psychologists, sociologists, and epidemiologists to conduct a longitudinal observational study.
- 9 June 2010
- Published by Springer Nature in BMC Geriatrics
- Vol. 10 (1) , 35
Open AccessThe Tokyo Oldest Old Survey on Total Health (TOOTH): A longitudinal cohort study of multidimensional components of health and well-being
With the rapid worldwide increase in the oldest old population, considerable concern has arisen about the social and economic burden of diseases and disability in this age group. Understanding of multidimensional structure of health and its life-course trajectory is an essential prerequisite for effective health care delivery. Therefore, we organized an interdisciplinary research team consisting of geriatricians, dentists, psychologists, sociologists, and epidemiologists to conduct a longitudinal observational study.
- 29 June 2007
- Vol. 27, 1493-502
Butyrate inhibits oral cancer cell proliferation and regulates expression of secretory phospholipase A2-X and COX-2.
Although surgical resection is the first choice for oral cancer, the development of new anti-cancer drugs is of great interest. The effect of the histone deacetylation inhibitor, sodium butyrate (NaBu) on oral cancer cell (OCC) HSC-3 and HSC-4 proliferation in vitro was investigated. The synthesis of rate-limiting enzymes such as sPLA2 (-IIA, -V, -X) and COX-2 was examined by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot, as well as PGE2 by ELISA. NaBu acted in a concentration-dependent manner. Over 3 mM, it inhibited OCC proliferation, due to increased p21 expression and cell cycle arrest in the G2/M-phase. At low concentration (< or = 1 mM), NaBu showed no effects or enhanced cell proliferation. NaBu also regulated COX-2 and sPLA2-X expression, and augmented PGE2 synthesis in OCC. These results indicate that NaBu is a novel candidate agent for the treatment of oral cancer. The treatment efficacy must be investigated in additional experiments considering NaBu concentration and tumor cell heterogeneity.
- 29 June 2007
- Vol. 27, 1493-502
Butyrate inhibits oral cancer cell proliferation and regulates expression of secretory phospholipase A2-X and COX-2.
Although surgical resection is the first choice for oral cancer, the development of new anti-cancer drugs is of great interest. The effect of the histone deacetylation inhibitor, sodium butyrate (NaBu) on oral cancer cell (OCC) HSC-3 and HSC-4 proliferation in vitro was investigated. The synthesis of rate-limiting enzymes such as sPLA2 (-IIA, -V, -X) and COX-2 was examined by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot, as well as PGE2 by ELISA. NaBu acted in a concentration-dependent manner. Over 3 mM, it inhibited OCC proliferation, due to increased p21 expression and cell cycle arrest in the G2/M-phase. At low concentration (< or = 1 mM), NaBu showed no effects or enhanced cell proliferation. NaBu also regulated COX-2 and sPLA2-X expression, and augmented PGE2 synthesis in OCC. These results indicate that NaBu is a novel candidate agent for the treatment of oral cancer. The treatment efficacy must be investigated in additional experiments considering NaBu concentration and tumor cell heterogeneity.
- 1 January 2004
- Published by Springer Nature
- Vol. 546, 207-214
Alternative and Comparative Medicine in Dentistry
- 1 January 2004
- Published by Springer Nature
- Vol. 546, 207-214
Alternative and Comparative Medicine in Dentistry
- 1 January 2004
- Published by Japanese Society of Oral Medicine in Journal of Japanese Society for Oral Mucous Membrane
- Vol. 10 (2) , 23-29
A Case of Necrotizing Sialometaplasia in Palate
- 1 January 2004
- Published by Japanese Society of Oral Medicine in Journal of Japanese Society for Oral Mucous Membrane
- Vol. 10 (2) , 23-29
A Case of Necrotizing Sialometaplasia in Palate